Semaglutide is effectively tolerated without any danger of hypoglycaemia in monotherapy but suffers from gastrointestinal adverse consequences. A big populace affected with COVID-19 infection were diabetic; therefore utilization of semaglutide in diabetic issues in addition to CV patients might be very much supportive in retaining health and fitness care process https://shermann777bmw0.targetblogs.com/profile